David Dalessio: Clinical Trials

3 trials sponsored by David Dalessio, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 3

Follow David Dalessio: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ghrelin Effect on Beta Cell Function in Health and Disease
Exendin (9-39), acyl ghrelin, saline - Diabetes
Not applicableUnknownDavid Dalessio302013-04-012013-04-04
Effect of GLP-1 on Postprandial Lipid Metabolism
Exendin-9, GLP-1, saline - Heart Disease
Not applicableUnknownDavid Dalessio422013-02-012013-01-04
Deacylated Ghrelin and Beta Cell Function
unacylated ghrelin, acyl ghrelin, combined acyl and desacyl ghrelin - the Diabetic Process
Not applicableUnknownDavid Dalessio302011-02-012012-11-14

Conditions studied

Diabetes Mellitus (1)  ·  Heart Diseases (1)  ·  Insulin Resistance (1)

Interventions

Sodium Chloride (3)  ·  acyl-ghrelin (2)  ·  exendin (9-39) (2)  ·  Glucagon-Like Peptide 1 (1)  ·  Injections (1)  ·  ghrelin, des-n-octanoyl (1)

Countries

United States (3)

Top investigators

David D'Alessio, MD (1)  ·  Jenny Tong, MD, MPH (1)  ·  Michelle R Adams, PhD (1)

Results publications

PMID 30065032

NIH funding

R03DK089090 (1)